BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• 

  Business

  TenSixteen Bio Plumbs Somatic Mosaicism for Source of Multiple Diseases

  TenSixteen Bio recently came out of stealth mode with $40 million in funding to target somatic mosaicism – particularly clonal hematopoiesis of indeterminate potential (CHIP).

  February 16, 2022

   · 

  3 min read

   · 

  Gail Dutton
• 

  Drug Development

  Star Therapeutics Starts a Family with Electra

  Star Therapeutics has exited stealth mode and announced a spin-off company, Electra Therapeutics.

  February 16, 2022

   · 

  3 min read

   · 

  Hayley Shasteen
• 

  FDA

  FDA Ad Com Comes Down Hard on Avenue’s IV Tramadol

  The FDA committee voted 8 yes and 14 no. The decision now goes back to the OND to decide the FDDR on Avenue Therapeutics’ IV Tramadol.

  February 16, 2022

   · 

  3 min read

   · 

  Mark Terry
• 

  Woman “Cured” of HIV with Umbilical Cord Blood Transplant

  Dr. Yvonne Bryson presented the case of an American woman who was apparently cured of HIV after a new transplant procedure that leverages donated umbilical cord blood.

  February 16, 2022

   · 

  3 min read

   · 

  Mark Terry
• 

  Rapid Aging in Rhesus Macaques after Hurricane could Translate to Humans

  Considering the biological similarities between rhesus macaques and humans, the research could suggest that people could suffer parallel effects from natural disasters.

  February 16, 2022

   · 

  7 min read

   · 

  Abbey Glasure
• Genetown

  Insulet to Present at Upcoming Investor Conferences - Feb 16, 2022

  Insulet Corporation, the global leader in tubeless insulin pump technology with its Omnipod® brand of products, announced that management will present at two upcoming investor conferences.

  February 16, 2022

   · 

  1 min read
• PharmaTher Announces Grant of U.S. Patent on Ketamine Formulation

  PharmaTher Holdings Ltd. is pleased to announce that the United States Patent and Trademark Office granted to the Company U.S. Patent No. 11,213,495, titled “Method and Composition for Decreasing the Psychotomimetic Side Effect and Addictive Disorder of Ketamine.”

  February 16, 2022

   · 

  4 min read
• Business

  Milestone Pharmaceuticals Announces Appointment of David Bharucha, M.D., Ph.D., as Chief Medical Officer

  Milestone Pharmaceuticals Inc. today announced the appointment of David Bharucha , M.D., Ph.D., as Chief Medical Officer, effective February 15, 2022.

  February 16, 2022

   · 

  6 min read
• Business

  CASI PHARMACEUTICALS ANNOUNCES PRELIMINARY FOURTH QUARTER AND FULL-YEAR 2021 REVENUES AND PROVIDES BUSINESS UPDATES

  CASI Pharmaceuticals, Inc. today announced preliminary and unaudited revenues for the fourth quarter and full-year 2021 and provided an update on key highlights for 2022.

  February 16, 2022

   · 

  9 min read
• Business

  Blueprint Medicines Reports Fourth Quarter and Full Year 2021 Results

  Blueprint Medicines Corporation (NASDAQ: BPMC) today reported financial results and provided a business update for the fourth quarter and full year ended December 31, 2021.

  February 16, 2022

   · 

  16 min read